As of April 2024 Merck has a market cap of $332.33 Billion. This makes Merck the world's 26th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $332.33 B | 20.3% |
2023 | $276.25 B | -1.79% |
2022 | $281.30 B | 45.31% |
2021 | $193.58 B | -6.46% |
2020 | $206.95 B | -10.38% |
2019 | $230.92 B | 16.57% |
2018 | $198.09 B | 29.22% |
2017 | $153.30 B | -5.55% |
2016 | $162.31 B | 10.49% |
2015 | $146.89 B | -8.86% |
2014 | $161.17 B | 10% |
2013 | $146.52 B | 18.25% |
2012 | $123.91 B | 7.84% |
2011 | $114.90 B | 3.45% |
2010 | $111.07 B | -2.2% |
2009 | $113.57 B | 76.71% |
2008 | $64.27 B | -49.09% |
2007 | $126.24 B | 33.57% |
2006 | $94.51 B | 36.18% |
2005 | $69.40 B | -2.22% |
2004 | $70.98 B | -30.84% |
2003 | $102.64 B | -19.46% |
2002 | $127.44 B | -6.04% |
2001 | $135.63 B |
On Apr 25th, 2024 the market cap of Merck was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $352.16 B | 5.97% | ๐บ๐ธ USA |
Novartis NVS | $198.81 B | -40.18% | ๐จ๐ญ Switzerland |
Pfizer PFE | $143.82 B | -56.72% | ๐บ๐ธ USA |
Abbott Laboratories ABT | $186.58 B | -43.86% | ๐บ๐ธ USA |
Eli Lilly LLY | $697.39 B | 109.85% | ๐บ๐ธ USA |
Amgen AMGN | $144.81 B | -56.43% | ๐บ๐ธ USA |
Sanofi SNY | $122.65 B | -63.09% | ๐ซ๐ท France |
Bristol-Myers Squibb BMY | $90.90 B | -72.65% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $83.98 B | -74.73% | ๐ฌ๐ง UK |
Teva Pharmaceutical Industries TEVA | $15.64 B | -95.29% | ๐ฎ๐ฑ Israel |